Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Gauvreau (Hamilton, Canada), J. Hohlfeld (Hannover, Germany), L. Boulet (Laval, Canada), D. Cockcroft (Saskatoon, Canada), B. Davis (Saskatoon, Canada), J. Fitzgerald (Vancouver, Canada), S. Korn (Mainz, Germany), O. Kornmann (Frankfurt, Germany), R. Leigh (Calgary, Canada), I. Mayers (Edmonton, Canada), H. Watz (Großhansdorf, Germany), S. Grant (Cambridge, United States of America), M. Jain (Cambridge, United States of America), M. Cabanski (Cambridge, United States of America), P. Pertel (Cambridge, United States of America), I. Jones (Cambridge, United States of America), J. Lecot (Suffolk, United Kingdom), P. O'Byrne (Hamilton, Canada). Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients. 3690

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Systemic IL-26 correlates with improved asthma control in children with allergic sensitization Source: International Congress 2018 – Molecular and cellular determinants of the developing lung Year: 2018 Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005 Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001 Late Breaking Abstract - The effects of allergen (DP/DF) on mucociliary transport of allergic rhinitis patients Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Induced sputum in children with mild-to-moderate atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002 Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007 Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006 Evaluation bronchial hyperresponsivness in patients with persistent allergic rhinitis Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Variants of allergic response in children with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 162s Year: 2004 Airways inflammation is related to bronchial responsiveness only in atopic subjects with rhinitis and/or asthma Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008 Diagnosis and treatment of allergic rhinitis in asthmatic children Source: Annual Congress 2009 - Allergic rhinitis and its impact on asthma in children Year: 2009 Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma. Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Efficacy of omalizumab in patients with concomitant allergic asthma and atopic dermatitis: a pilot study Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthma Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005 The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta Source: International Congress 2016 – Asthma management Year: 2016 Prognosis of allergic and non-allergic asthma Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012